Posted in:News PTAB Institutes IPR filed by Celltrion for Rituximab Patent By C. Nichole Gifford February 28, 2017 Comments are off Celltrion, Inc. (“Celltrion”) filed a petition with the Patent Trial and Appeal Board (“PTAB”) on August 15, 2016 for inter partes... Read more Tagged with: Celltrion, Genentech, IPR, Legal, Mabthera, News, PTAB, Rituxan®, Rituximab, Roche, USPTO http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:News Celltrion Files IPR Petition on Herceptin® Patent By C. Nichole Gifford February 22, 2017 Comments are off Celltrion, Inc. (“Celltrion”) filed a new petition with the Patent Trial and Appeal Board (“PTAB”) on February 21, 2017 for inter... Read more Tagged with: Celltrion, Genentech, Herceptin®, IPR, Legal, News, PTAB, Roche, Teva, trastuzumab, USPTO http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:News Coherus Files Four IPR Petitions on Humira® Patent By C. Nichole Gifford February 1, 2017 Comments are off Coherus Biosciences, Inc. (“Coherus”) has filed four petitions with the Patent Trial and Appeal Board (“PTAB”) for inter partes... Read more Tagged with: adalimumab, Amgen, Coherus, Humira®, Invalidity, IPR, Legal, News, PTAB, USPTO, Validity http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:News Hospira Files Two More IPR Petitions on Herceptin® Patents By C. Nichole Gifford January 31, 2017 Comments are off Hospira, Inc. (“Hospira”) filed two additional new petitions with the Patent Trial and Appeal Board (“PTAB”) on January 30, 2017... Read more Tagged with: Genentech, Herceptin®, Hospira, IPR, Legal, News, Pfizer, PTAB, Roche, trastuzumab, USPTO http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:News Hospira Files Three IPR Petitions on Herceptin® Patents By C. Nichole Gifford January 21, 2017 Comments are off Hospira, Inc. (“Hospira”) filed three petitions with the Patent Trial and Appeal Board (“PTAB”) on January 20, 2017 for inter... Read more Tagged with: Genentech, Herceptin®, Hospira, IPR, Legal, News, Pfizer, PTAB, Roche, trastuzumab, USPTO http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus